GREGoRi Technology Integration Center (U01, Clinical Trials Optional)
- Response deadline
- Oct 30, 2026 Due in 58 days
- Date posted
- Jun 18, 2026
- Source
- Open notice
Description
The Genomics Research to Elucidate the Genetics of Rare Diseases:innovation (GREGoRi) initiative seeks to accelerate a paradigm shift in rare disease diagnosis by reimagining the tools, molecular technologies and analytical approaches used to identify the causal gene(s) and/or variant(s) underlying rare genetic disorders. The purpose of this Notice of Funding Opportunity is to establish the GREGoRi Technology Integration Center, which will enable the development of standards and best practices for applying new and emerging molecular methods in rare disease diagnosis. A major deliverable of the Center will be a multidimensional dataset that can be used for the development and benchmarking of novel tools and strategies that facilitate rare disease diagnosis.
Classifications
- NAICS93.172
Documents (1)
- DownloadRFA-HG-27-012-Full-Announcement.htmltext/html;charset=UTF-8146 KB
Contacts
Similar contracts
- GREGoRi Innovation Projects (U01 Clinical Trial Optional)Due Oct 30, 2026
- GREGoRi Data Coordination and Outreach Center (U01, Clinical Trials Not Allowed)Due Oct 30, 2026
- NIH Research Educational Program - Mentoring Activities & Networks (Parent R25/UE5 - Clinical Trial Not Allowed)Due May 5, 2029
- NIH Research Education Program - Courses, Curriculum & Methods (Parent R25 - Clinical Trial Not Allowed)Due May 25, 2029
- Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)Due Nov 30, 2028
- Supporting Talented Early Career Researchers in Genomics (R01 Clinical Trial Optional)Due Feb 26, 2027